These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 30326922)

  • 1. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
    Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
    Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
    Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
    Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
    Li J; Su T; Yang L; Zhang C; He Y
    Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
    Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
    Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat Shock Factor 1 Predicts Poor Prognosis of Gastric Cancer.
    Kim SJ; Lee SC; Kang HG; Gim J; Lee KH; Lee SH; Chun KH
    Yonsei Med J; 2018 Nov; 59(9):1041-1048. PubMed ID: 30328318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat Shock Factor 1 in Relation to Tumor Angiogenesis and Disease Progression in Patients With Pancreatic Cancer.
    Lin Q; Xiao G; Wang G; He Q; Xu L; Qiu P; Tan S; Gong M; Wen J; Xiao X
    Pancreas; 2020; 49(10):1327-1334. PubMed ID: 33122521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer.
    Han YL; Chen L; Qin R; Wang GQ; Lin XH; Dai GH
    World J Gastroenterol; 2019 Apr; 25(15):1828-1839. PubMed ID: 31057297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
    Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
    Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
    Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
    Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
    Min C; Zhang A; Qin J
    Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
    Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
    Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
    J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
    Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
    Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.